Conceptio
›
acute-myeloid-leukemia
Topic
acute-myeloid-leukemia
Knowledge-graph topic
· documents ABOUT acute-myeloid-leukemia across the archive
438
Documents about acute-myeloid-leukemia
Documents about acute-myeloid-leukemia
Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
#390928
ClinicalTrials.gov
MG4101 for Refractory or Relapsed AML
#828025
ClinicalTrials.gov
A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection
#867597
ClinicalTrials.gov
IDH1/2 Mutational Analysis in AML Patients: Diagnosis and Follow-up
#871982
ClinicalTrials.gov
Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML
#918644
ClinicalTrials.gov
Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML
#1030087
ClinicalTrials.gov
Prophylactic Application of Donor-derived TCM After Allogeneic HSCT
#1044512
ClinicalTrials.gov
Role of Adrenomedullin in Leukemic Endosteal/Vascular Niches
#1047311
ClinicalTrials.gov
Risk-adapted Therapy for Adult Acute Myeloid Leukemia.
#873936
ClinicalTrials.gov
Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
#907301
ClinicalTrials.gov
Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)
#867750
ClinicalTrials.gov
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
#803627
ClinicalTrials.gov
A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.
#912464
ClinicalTrials.gov
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
#842082
ClinicalTrials.gov
Lösemik kök hücrelerde erken embriyonik kök hücre transkripsiyon faktörlerinin ekspresyonunun araştırılması
#1038272
DSpace at Dokuz Eylul University
Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation
#829470
ClinicalTrials.gov
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
#829448
ClinicalTrials.gov
Prophylactic DLI for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy
#993068
ClinicalTrials.gov
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
#866857
ClinicalTrials.gov
HVA vs IA/DA or VA in the Treatment of ND HR-AML
#840678
ClinicalTrials.gov
Natural Killer Index From Hematopoietic Stem Cell Graft
#889583
ClinicalTrials.gov
Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
#845424
ClinicalTrials.gov
An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)
#864147
ClinicalTrials.gov
Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
#363602
ClinicalTrials.gov
3-AP and Cytarabine in Treating Patients With Hematologic Cancer
#840768
ClinicalTrials.gov
Artificial intelligence–based prognostic models in acute myeloid leukemia: systematic review and meta-analysis.
#30561
NCBI PubMed Central
Nucleophosmin mutated blasts express high levels of spontaneous apoptosis in acute myeloid leukemia (AML)
#337761
IRIS
Integrative Mutation-Centered Transcriptomic Analysis of Driver-Specific Programs and Biomarker Candidates in Acute Myeloid Leukemia
#403991
KFUPM ePrints
Patient and oncologist expectations of functional prognosis among older adults with acute myeloid leukemia.
#440677
NCBI PubMed Central
Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant
#831561
ClinicalTrials.gov
Hematopoietic Stem Cell Microtransplantation for in AML
#1010571
ClinicalTrials.gov
Decitabine and Talazoparib in Untreated AML and R/R AML
#1033346
ClinicalTrials.gov
A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia
#832007
ClinicalTrials.gov
Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
#1045956
ClinicalTrials.gov
Immunotoxin in Treating Patients With Leukemia or Lymphoma
#914365
ClinicalTrials.gov
High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD
#907512
ClinicalTrials.gov
An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha
#992123
ClinicalTrials.gov
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study
#357121
Gestión del Repositorio Documental de la Universidad de Salamanca
Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies
#836103
ClinicalTrials.gov
Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia
#886202
ClinicalTrials.gov
CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma
#143568
ClinicalTrials.gov
Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)
#903914
ClinicalTrials.gov
Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML
#801888
ClinicalTrials.gov
TRIM22-mediated ubiquitin-dependent degradation of FLT3-ITD overcomes TKI resistance in acute myeloid leukemia.
#334874
NCBI PubMed Central
TRIM24 stabilizes the p110 CUX1 oncoprotein via USP10 to promote chemoresistance in acute myeloid leukemia.
#685862
NCBI PubMed Central
NK Cell Therapy for AML
#806149
ClinicalTrials.gov
Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
#862808
ClinicalTrials.gov
IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
#890542
ClinicalTrials.gov
Azacytidine Plus FLAG for Relapsed or Refractory AML
#894414
ClinicalTrials.gov
A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML
#911643
ClinicalTrials.gov
← Previous
Page 14 of 19
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.